Episode 29: Using Mask-Free NIV for Spontaneously Breathing COVID-19 Patients

BreatheTV Episode 29

Using Mask-Free NIV for Spontaneously Breathing COVID-19 Patients

The ventilatory support of NiPPV with the comfort of humidified high flow?

Unlike NiPPV, Hi-VNI Technology is low pressure and mask-free.

In this guide, learn if Mask-Free NIV is an option for spontaneously breathing patients in your hospital.

This 15 page guide includes:

  • How Hi-VNI Technology works
  • Selecting Mask-Free NIV interfaces
  • Detailed Clinical trial overview

No Mask. No Problem. Mask-Free NIV

for Spontaneously Breathing Patients


eBook Download

References

1. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected – Interim guidance 13 March 2020
2. WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 2020
3. Li, et al., Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-infected Pneumonia. NEJM 2020;382:1199-1207.
4. Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19); Alhazzani et al.; JCCM 2020
5. Yang X , Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; (published online Feb 24.) https://doi.org/10.1016/S2213-600(20)30079-5
6. https://www.icnarc.org/About/Latest-News/2020/03/27/Report-On-775-Patients-Critically-Ill-With-Covid-19
7. Arentz (JAMA 2020) and Bhatraju (NEJM 2020), From CDC COCA 4/2/20
8. Sun Q, Qiu H, Huang M, & Yang Y. Ann. Intensive Care (2020) 10:33 https://doi.org/10.1186/s13613-020-00650-2
9. Whittle et al. Respiratory Support for Adult Patients with COVID-19. JACEP OPEN, April 2020. https://doi.org/10.1002/emp2.12071
10. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive care medicine. 2020;DOI:10.1007/s00134-020-06033-2.
11. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html
12. https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
13. Leung et al. Comparison of High Flow Nasal Cannula Versus Oxygen Face Mask for Environmental Bacterial Contamination in Critically Ill Pneumonia Patients: A Randomized Controlled Crossover Trial. Journal of Hospital Infection 101 (2019) 84e87
14. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. The European respiratory journal. 2019;53(4). doi:10.1183/13993003.02339-2018
15. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4):e35797
16. The Australian and New Zealand Intensive Care Society (ANZICS) COVID-19 Guidelines – 16 March 2020- https://www.anzics.com.au/wp-content/uploads/2020/03/ANZICS-COVID-19-Guidelines-Version-1.pdf
17. Leonard S, Atwood CW Jr, Walsh BK, DeBellis RJ, Dungan GC, Strasser W, Whittle JS, Preliminary Findings of Control of Dispersion of Aerosols and Droplets during High Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask: Implications for High Flow Nasal Cannula, CHEST (2020), doi: https://doi.org/10.1016/j.chest.2020.03.043
18. Leonard S, Volakis L, DeBellis R et al. Transmission Assessment Report: High Velocity Nasal Insufflation (HVNI) Therapy Application in Management of COVID-19. Vapotherm. March 2020.
19. Doshi P, Whittle JS, Bublewicz M, et al. High-Velocity Nasal Insufflation in the Treatment of Respiratory Failure: A Randomized Clinical Trial. Ann Emerg Med 2018;72:73-83 e5.
20. Wu Z, McGoogan JM, (2020) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA; doi: 10.1001/jama.2020.2648
21. Dysart K, Miller T, Wolfson M, Shaffer T. Research in high flow therapy: Mechanisms of action. Respiratory Medicine. 2009; 103: 1400-05
22. Ding et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Critical Care; 24(1):28 2020
2020-05-01T11:51:36-04:00May 1|BreatheTV|
Go to Top